tiprankstipranks
Trending News
More News >
Alnylam Pharmaceuticals (GB:0HD2)
LSE:0HD2
Advertisement

Alnylam Pharma (0HD2) Similar Shares

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Alnylam Pharma
$443.46
$56.78B
1,796.21
75.43%
19 Buy
4 Hold
0 Sell
Strong Buy
Incyte
$105.65
$20.72B
17.71
41.24%
8 Buy
10 Hold
1 Sell
Moderate Buy
Vertex Pharmaceuticals
$432.17
$107.58B
29.88
-7.47%
14 Buy
8 Hold
0 Sell
Moderate Buy
Argenx Se
$917.63
$55.96B
43.12
51.13%
19 Buy
2 Hold
0 Sell
Strong Buy
Genmab
$31.40
$19.65B
13.45
50.85%
5 Buy
1 Hold
1 Sell
Moderate Buy
BioNTech SE
$102.70
$23.98B
-13.36%
13 Buy
3 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:0HD2
Alnylam Pharma
443.46
190.68
75.43%
INCY
Incyte
105.65
30.20
40.03%
VRTX
Vertex Pharmaceuticals
432.17
-32.39
-6.97%
ARGX
Argenx Se
917.63
303.04
49.31%
GMAB
Genmab
31.92
10.76
50.85%
BNTX
BioNTech SE
102.70
-18.02
-14.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis